up home page bottom

French German version Spanish version Italian version

header image

Monthly Archives: April 2008

A Guide to Drug Safety Terms at FDA

April 11, 2008 – 10:29 am

Inconvenient Woman readers know that I’m not an FDA fan.
In my opinion, the troubled agency’s close ties and financial dependence on Big Pharma
has been weakened its ability to perform its primary function — protecting the public. The FDA’s documented failure to impartially judge the veracity of drug trial results and enforce safety oversight of the […]

By H. Sandra Chevalier-Batik | Posted in Big Pharma Watch, FDA Approvals, FDA Clinical Trials | Comments (0)

Johnson & Johnson’s Pre-Emption Defense Over Safety of Birth Control Patch

April 10, 2008 – 12:30 pm

IN THE COURTS: New York Times Examines Johnson & Johnson’s Pre-Emption Defense Over Safety of Birth Control Patch
From DAILY WOMEN’S HEALTH POLICY REPORT, [April 8, 2008]
The New York Times on Sunday examined Johnson & Johnson’s use of the legal doctrine of preemption to defend against claims that the birth control patch Ortho Evra causes blood […]

By H. Sandra Chevalier-Batik | Posted in Big Pharma Watch, Birth Control | Comments (0)

There is A New Book in the Iconic Woman Bookshelf…

April 9, 2008 – 9:24 am

The Secret History of the War on Cancer
By Devra Davis, PhD, MPH
Review by Leslie Botha, Holy Hormones Honey!
In a recent interview on CSPAN Davis stated, “For much of its history, the cancer war has been fighting the wrong battles, with the wrong weapons, against the wrong enemies.”

The Secret History of the War on Cancer by […]

By H. Sandra Chevalier-Batik | Posted in Big Pharma Watch, Breast Cancer, Cancer Research, Cervical Cancer, FDA Clinical Trials, FDA Conflict of Interest, Follow The Money, HPV Infection, HRT, PAP Test, Proactive Nutrition, Questionable Medicine, STD Infection | Comments (0)

Vytorin — Another FDA Failure To Protect Public

April 8, 2008 – 10:12 am

Big Pharma Giants Schering and Merck
Take Heavy Criticism Over Vytorin Failure
This week Merck executives are very grateful for the revenue predictions for their blockbuster HPV vaccine, GARDASIL. Profits are predicted to climb from $300 million to $4 billion over the next year. After the Vytorin debacle —they’re going to need the cash.
So lock up your […]

By H. Sandra Chevalier-Batik | Posted in Big Pharma Watch, FDA Clinical Trials, Follow The Money | Comments (0)

Bimbos R’ Us

April 7, 2008 – 10:24 am

Universal Out Rage Rings Peal Over French Website Developer
When a French website called Ma-Bimbo quickly boasts 1.2 million subscribers, Nicholas Jacquart, developer and entrepreneur, moved to South London with a 30-year-old businessman, Chris Evans and set up Ouza Ltd to try his luck with Baby British Bimbos.

Looks like he gauged the market correctly. Recently […]

By H. Sandra Chevalier-Batik | Posted in Exploitive Behavior, Follow The Money | Comments (0)

Schools Need More ‘Frank Talk’ in Sex Education Courses To Curb STDs

April 3, 2008 – 10:21 am

A recent CDC study that found that about 25% of U.S. girls and young women ages 14 to 19 have at least one of four common sexually transmitted infections is “enough to make you wonder why schools don’t do a better job of sex education,” Washington Post columnist Courtland Milloy writes in an opinion piece.
Milloy […]

By H. Sandra Chevalier-Batik | Posted in STD Infection, Sex Education | Comments (0)

Public Interest Mashup* Follows Political Money Trail

April 2, 2008 – 8:40 am

Money and Politics: Illuminating the Connection
MAPLight.org is developing a mashup* that shows a correlation between political campaign contributions and the way lawmakers vote.
During the Watergate scandal that eventually toppled President Richard Nixon, confidential source “Deep Throat” advised two enterprising Washington Post reporters to “follow the money” to uncover the scandal’s ringleaders.
MAPLight.org, a small, not-for-profit company, […]

By H. Sandra Chevalier-Batik | Posted in Follow The Money | Comments (0)